Concerns have been reported to the United Kingdom National Patient Safety Agency, warning that cementing the femoral component during hip replacement surgery for fracture of the proximal femur may increase peri-operative mortality.
The number of patients who sustain a fracture of the proximal femur continues to rise annually, and the associated morbidity and mortality remain extremely high. 1 Roughly half these fractures are intracapsular, and most are displaced. There remains some debate about the best treatment for this group of patients, but hemiarthroplasty is currently the most commonly performed surgical procedure for displaced intracapsular fracture of the proximal femur. 2 Both hemiarthroplasty and total hip replacement have been shown to give good functional results. 3 The femoral component of a hip replacement can be cemented or uncemented. Current evidence suggests that a cemented prosthesis gives the best functional outcome following femoral neck fracture. 4 However, in March 2009 the United Kingdom National Patient Safety Agency (NPSA) produced a report that raised concern about the mortality associated with the use of bone cement in patients undergoing hip replacement for a fracture of the proximal femur. 5 In response, Timperley and Whitehouse 6 published an editorial in which the relevant literature was reviewed. They found that the reported incidence of death associated with the use of cement was very low, but concluded that 'there is clearly a need for a National Hip Fracture Database to provide more accurate and relevant data in order to plan better treatment for this vulnerable group of patients'.
We report the results of a cross-sectional study that used a range of demographic variables to describe and model the post-operative mortality of patients with a fracture of the neck of the femur which was treated by hemiarthroplasty or total hip replacement. Our aim was to define any differences between cemented and uncemented replacement surgery in this group using data from the United Kingdom National Hip Fracture Database (NHFD).
Materials and Methods
Characteristics of the NHFD. The National Hip Fracture Database records demographic, operative and peri-operative intervention and basic outcome data about patients treated in the United Kingdom for a fracture of the proximal femur. From 1 April 2009 to 31 March 2010, data on 36 556 such patients were available from 129 contributing hospitals, with detailed data fields completed for each patient.
The following data were recorded for each patient: hospital; gender; the location from which the patient was admitted (own home/sheltered housing, already in hospital, acute hospital, residential care/nursing home/long-term care (LTC) hospital, rehabilitation unit, other or unknown); whether the patient needed to be accompanied to walk indoors or outdoors (no/yes, wheelchair or bedbound, or unknown); an assessment of the patient's walking ability indoors and outdoors (regularly walked without aids, regularly walked with one aid, regularly walked with two aids or frame, used an electric buggy, wheelchair or bedbound, or unknown); the fracture type (intertrochanteric, intracapsular displaced, intracapsular undisplaced, subtrochanteric or other); American Society of Anesthesiologists (ASA) grade 7 (1, normal healthy individual; 2, mild systemic disease that does not limit activity; 3, severe systemic disease that limits activity but is not incapacitating; 4, incapacitating systemic disease which is constantly lifethreatening; 5, moribund: not expected to survive 24 hours with or without surgery; or unknown); the type of replacement (total hip replacement, unipolar or bipolar hemiarthroplasty); whether this was cemented (yes/no); the patient's age in years; the time between admission and surgery (days); the type of operation (joint replacement, internal fixation, no operation performed, or other); and the patient's status at discharge (dead or alive). Statistical analysis. Mixed effects logistic regression models, which included fixed and random effects, were used to assess the significance of the observed explanatory variables (e.g. age, ASA grade etc.) on the binary outcome event of death at discharge. For binary response data, logistic regression models incorporating and estimating the influence of random effects are now very widely used. This general class of model consists of linear models that are expressed as a function of both fixed effects, parameters corresponding to an entire population or certain repeatable levels of experimental factors, and random effects, parameters corresponding to individual experimental units drawn at random from a population. Mixed effects logistic regression is simply a generalisation of conventional logistic regression (where all the parameters are considered to be fixed effects) in which, for example for the models used here, the intercept terms are allowed to vary between hospitals according to an assumed probability distribution (usually the normal distribution). In essence, the random effects incorporated in the model are a convenient way of modelling the individual heterogeneity for hospitals, without having to introduce and estimate 129 parameters to model the individual effects of the hospitals, which in our model are viewed as essentially a random sample of hospitals from a wider population. In general, interest centres on making inferences about the regression coefficients for the fixed effects (e.g. age, ASA grade etc.), the random effects being regarded as nuisance parameters. The fixed effect coefficients are interpreted, as in conventional logistic regression, as additive effects on the log of the odds for a unit change in the explanatory variable. In the case of a binary explanatory variable, for example gender, the exponent of the estimated coefficient is the odds of death for, say, males compared to females.
Model development was undertaken using the freeware statistical package R 8 using the function library lme4. 9 For nested mixed effects models differing only in fixed effects structure, likelihood ratio tests were used for model comparison. A stepwise regression algorithm was used for explanatory variable selection, with variables introduced to the model after ranking in an initial univariate analysis. As the amount of missing data was expected to be relatively small (< 5%) a complete case approach was considered to be appropriate for this setting. Diagnostic analyses, residual plots and a Shapiro-Wilk normality test were used to assess the model assumptions. Approximate 95% confidence intervals (CI) for the estimated model parameters were constructed based on asymptotic normality.
Results

Between 1 April 2009 and 31
March 2010, data on 36 556 patients were collected from 129 hospitals. A small number of patient records (130) had invalid dates, so these were excluded from the analysis. The types of operation carried out on the 36 426 patients included in the study are shown in Table I . A total of 17 257 patients had joint replacement surgery, and complete records were available for 16 496 (95.6%) of these.
The median age of the 16 496 patients who underwent joint replacement was 84 years (interquartile range (IQR) 78 to 89), with a gender ratio of slightly less than 3:1 (12 248 women to 4248 men). There were 1106 deaths before discharge, which represent 6.7% of the patients undergoing hemiarthroplasty or total hip replacement. Table II gives a complete description of the main patient variables, by uncemented and cemented groups.
Stepwise regression analysis showed that, after likelihood ratio tests, the following variables were statistically significant in the final model for predicting death at discharge; in order of importance, these were All twofactor interactions between the cementing factor and the other model variables (ASA grade, age, accompanied outdoors and arthroplasty) were added to the final model individually and tested for significance using likelihood ratio tests. All p-values from the tests were > 0.05, indicating that none of the interaction terms improved the model fit; that is, there was no evidence to suggest that the effect of cementing on death was modified by any of these other variables. Estimated model coefficients are shown in Table III and presented graphically in Figure 1 , with 95% CI indicating where coefficients differed significantly from the reference level (where the log odds ratio (OR) is set to zero). The interpretation of the coefficients was such that larger coefficients increased the odds of death at discharge. Therefore, the risk of death at discharge increased both with ASA grade and age at admission in a linear fashion (Fig. 1) . Estimated coefficients indicated that an ASA grade of 5 increased the OR of death at discharge to 53.7 (95% CI 6.8 to 422.0), relative to an ASA grade of 1, and that the OR of death at discharge was 4.2 (95% CI 2.0 to 8.6) for patients > 90 years of age relative to those < 65 years of age. Patients who needed to be accompanied outdoors and who used a wheelchair or were bedbound at admission had estimated ORs of 1.5 (95% CI 1.3 to 1.8) and 1.9 (95% CI 1.5 to 2.5), respectively, indicating that these factors increased the probability of death at discharge relative to the patients who did not need to be accompanied outdoors. Patients undergoing total hip replacement (THR) had a lower probability of death at discharge, OR 0.40 (95% CI 0.23 to 0.69), than those undergoing hemiarthroplasty. There was no difference between bipolar or unipolar hemiarthroplasty. The overwhelming majority (907 out of 1103) of the relatively small number of THRs (6.7%) were in patients who did not need help to walk outdoors, suggesting that this group was generally fitter than average. Therefore, the lower risk of death for THR patients is likely to be driven by patient fitness rather than by the procedure itself. Men were more likely to die than women: OR 1.6 (95% CI 1.4 to 1.8). The effect of cementing on death at discharge was small but significant: an OR of 0.83 (95% CI 0.72 to 0.96) indicated that the risk of death after adjusting for all the other model factors (e.g. the heterogeneity between hospitals, age, ASA grade) was lower for the cemented than for the uncemented group. Most centres (121 out of 129) performed both cemented and uncemented replacements. The median percentage of cemented to total (cemented plus uncemented) arthroplasties performed at a centre was 73.4% (IQR 39.3 to 91.7), indicating that the effects of cementing on peri-operative mortality were not centredriven, i.e. most centres performed both cemented and uncemented replacements.
A Shapiro-Wilk normality test on the estimated random effects (hospitals) showed that there was no evidence to indicate that these were not normally distributed (p = 0.551), which confirmed the model assumptions for these effects. That is, the hospitals provided a sample from the wider population of hospitals, and the sample was such that the heterogeneity in probabilities of death at discharge were approximately normally distributed in a manner which suggested that the sample was representative of the wider population.
Discussion
Bone cement is a reliable method of fixing a femoral component to the femur: contemporary techniques are associated with a very low mortality in patients who undergo a total hip replacement for arthritis. 10 However, those with a fracture of the proximal femur are generally older than those with arthritis and are less fit. Consequently, they may be less able to tolerate the haemodynamic changes that occur as a result of pressurisation of cement in the femoral canal. 11 Although the overall incidence of death with a cemented femoral component is low, 6 there were enough reports to the National Patient Safety Agency for it to raise concern about the mortality associated with the use of bone cement in patients undergoing hip replacement for fracture of the neck of the femur.
This study used data from the National Hip Fracture Database (NHFD). The NHFD is a web-based audit tool that was launched in 2007 to reduce variation in clinical practice and drive improvements in care for patients with a fracture of the proximal femur. Over 90% of hospitals in the United Kingdom now submit data to the NHFD. It is therefore likely to be a sensitive tool for detecting rare but important events associated with surgery.
In this study, an unadjusted analysis of the risk of death associated with cementing the femoral component gave an OR of 0.66 (95% CI 0.57 to 0.76), which indicates a significantly lower risk of death at discharge for the cemented group. However, the unadjusted analysis does not take into account differences in the baseline characteristics of the cemented versus the uncemented groups of patients, the latter group were slightly older and more frail (Table II) . This might reflect the practice in some hospitals where cemented arthroplasty is reserved for younger, more active patients.
However, the OR from the logistic regression model (0.83, 95% CI 0.72 to 0.96) shows that the risk of death after adjusting for all the other factors (e.g. the heterogeneity between hospitals, age, ASA grade etc.) was still significantly lower for the cemented than for the uncemented group.
There are limitations associated with this study, and indeed with all investigations of large, complicated datasets. Although remuneration for hospitals treating this group of patients is now linked to the submission of data to the NHFD, this submission remains voluntary. Similarly, although remuneration is not linked to mortality, it is possible that selective reporting by some institutions, or indeed surgeons, may bias the results. Furthermore, no model can account for all of the possible explanatory variables that might influence the results. There are limitations inherent in the data collected for the NHFD. For example, ASA grade Log odds ratio (dead at discharge)
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is the most common method for assessing peri-operative risk but is an incomplete assessment of an individual patient's physiological status. Subtle differences between patient groups may not be detected by adjusting for ASA grade. It is possible that the logistic regression analysis did not adequately adjust for some important confounders between the groups. We think this is unlikely given the breadth of data available for each patient, and certainly it seems unlikely given the observed difference between unadjusted and adjusted risks in this study, but some unknown confounders could qualitatively change our perception of risks between cemented and uncemented groups.
Another issue is that we chose 'death at discharge' as a marker of peri-operative mortality. This measure includes all deaths, at all time-points, up to the point of discharge from hospital, i.e. it is not specific to intra-operative death. However, as some patients who suffer an event related to cementing will survive the operation itself but may die later because of associated complications, we feel that this measure gives the most complete assessment of the risk of death with cemented joint replacement.
There is a potential danger in extrapolating this data to other health-care settings. Although most hospitals in the United Kingdom now submit data to the NHFD, it is possible that there are variations in clinical practice in the other hospitals, and indeed in other countries. These results only apply to patients with fractures, i.e. they cannot be extrapolated to the use of cemented versus uncemented arthroplasty for patients with arthritis of the hip. There is also a concern about the 'completeness' of the data submitted to the database: the figures are improving, but few hospitals submit data on all their patients with a fracture of the proximal femur. Finally, there are issues pertaining to missing data within the submitted dataset.
The limitations described above mean that it is not possible to show that cementation never causes individual adverse reactions. However, the outcomes recorded by the United Kingdom NHFD show that overall peri-operative mortality is significantly lower when cement is used. This suggests that the concerns of the NPSA about the general safety of bone cement are likely to be unjustified. As cemented joint replacement has been shown to give better functional results than uncemented, 4 the NHFD will continue to use cemented fixation of the femoral component as a marker of quality for patients with an intracapsular fracture of the neck of the femur.
